Noncytolytic CD8 T cell-mediated suppression of HIV replication

Springer Seminars in Immunopathology

Volumn 18, Issue 3, 1997, Pages 355-369

  Greenberg, Michael L ^a   Lacey, Simon F ^a   Chen, Chin Ho ^a   Bolognesi, Dani P ^a   Weinhold, Kent J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CHEMOKINE;

ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS REPLICATION;

CD8-POSITIVE T-LYMPHOCYTES; CHEMOKINES; CYTOTOXICITY, IMMUNOLOGIC; HIV; HIV INFECTIONS; HUMANS; IMMUNITY, CELLULAR; MODELS, BIOLOGICAL; RECEPTORS, HIV; VIRUS REPLICATION;

EID: 0031048051     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00813503     Document Type: Article

References (64)

1. Albert J, Gaines H, Sonnerborg A, Nystrom G, Pehrson PO, Chiodi F, Sydow M von, Moberg L, Lidman K, Christensson B (1987) Isolation of human immunodeficiency virus (HIV) from plasma during primary HIV infection. J Med Virol 23:67
2. Baier M, Werner A, Bannert N, Metzner K, Kurth R (1995) HIV suppression by interleukin-16. Nature 378:563
3. + T cell suppressor activites. J Immunol 156:4476
4. Barre-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vezinet-Brun F, Rouzioux C, Rozenbaum W, Montagnier L (1983) Isolation of a T lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220:868
5. Biesinger B, Muller-Fleckenstein I, Simmer B, Lang G, Wittmann S, Platzer E, Desrosiers R, Fleckenstein B (1992) Stable growth transformation of human T lymphocytes by herpesvirus saimiri. Proc Natl Acad. Sci. USA 89:3116
6. + cytotoxic T lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 68:6103
7. + cells. J Virol Methods 25:293
8. + cells. Evidence for a soluble inhibitor J Immunol 144:2961
9. + T cells but not by rIFN-β, rIFN-γ, or by recombinant tumor necrosis factor-α. J Acquir Immune Defic Syndr 4:480
10. Buchbinder SP, Katz MH, Hessol NA, O'Malley PM, Holmberg SD (1994) Long-term HIV-1-infection without immunologic progression. J Acquir Immune Defic Syndr 8:1123
11. Cao Y, Qin L, Zhang L, Safrit J, Ho DD (1995) Virological and immunological characterization of long-term survivors of human immunodeficiency virus type I infection. N Engl J Med 332:201
12. + cells from infected and uninfected chimpanzees. Cell Immunol 132:246
13. + T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: a novel antiviral mechanism. AIDS Res Hum Retrov 9:1079
14. Clark SJ, Saag MS, Decker WD, Campbell-Hill S, Roberson JL, Veldkamp PJ, Kappes JC, Hahn BH, Shaw GM (1991) High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1-infection N Engl J Med 324:954
15. + T cells. Science; 270:1811
16. + human peripheral blood lymphocytes are potent sources of macrophage inflammatory protein-1α, interleukin-8 and RANTES. Eur J Immunol 25:751
17. Coombs RW, Collier AC, Allain J-P, Mikora B, Leuther M, Gjerset GF, Corey L (1989) Plasma viremia in human immunodeficiency virus infection. N Engl J Med 321:1626
18. + cells is not lentivirus specific. J Acquir Immune Defic Syndr Res Human Retroviruses 11:1321
19. Daar ES, Moudgil T, Meyer RD, Ho DD (1991) Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med 324:961
20. Dalgleish AG, Beverly PCL, Clapham PR, Crawford DH, Greaves MF, Weiss RA (1984) The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312:763
21. Deng HK, Choe S, Ellmeier W, Liu R, Unutmaz D, Burkhart M, Marzio PD, Marmon S, Sutton RE, Hill CM, Davis C, Peiper SC, Schall TJ, Littman DR, Landau NR (1996) Identification of a major coreceptor for entry of primary isolates of HIV-1. Nature 381: 661
22. + cells is mediated by the chemokine receptor C-C CKR-5. Nature 381: 667
23. D'Souza MP, Mathieson BJ (1996) Early phases of HIV-1-infection: workshop summary. AIDS Res Hum Retrov 12: 1
24. Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, Haase AT (1993) Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362:359
25. + T lymphocytes of African green monkeys secrete an immunodeficiency virus-suppressing lymphokine. Proc Nat Acad Sci USA 91:7207
26. Eyster ME, Ballard JO, Gail MH, Drummond JE, Goedert JJ (1989) Predictive markers for the acquired immunodeficiency syndrome (AIDS) in hemophiliacs: persistence of p24 antigen and low T4 cell count. Ann Intern Med 110:963
27. Feng Y, Broder CC, Kennedy PE, Berger EA (1996) HIV-1 entry co-factor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science; 272:872
28. Gallo RC, Salahuddin SZ, Popovic M, Shearer GM, Kaplan M, Haynes BF, Palker TJ, Redfield R, Oleske J, Safai B, White G, Foster P, Markham PD (1984) Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224:500
29. + T cells correlates with CD4 counts and clinical stage of disease. Clin Exp Immunol 97:68
30. Ho DD, Moudgil T, Alam M (1989) Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med 321:1621
31. Hogervorst E, Jurriaans S, Wolf F de, Wijk A van, Wiersma A, Valk M, Roos M, Gemen B van, Coutinho R, Miedema F, Goudsmit J (1995) Predictors for non- and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels. J Infect Dis 171:811
32. + cell clones derived from HIV-infected and Uninfected individuals. Cell. Immunol. 159:271
33. + lymphocytes. J Immunol 140:2237
34. Kirchfoff F, Greenough TC, Brettler DB, Sullivan JL, Desrosiers RC (1995) Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1-infection. N Engl J Med 332:228
35. Klatzmann D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend T, Gluckman J-C, Montagnier L (1984) T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312:767
36. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, Farthing C, Ho DD (1994) Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 68:4650
37. Lacey SF, Chen C-H, Weinhold KJ, Greenberg ML (1995) Suppression of HIV-1 replication by primary and transformed CD8 cells. AIDS Res Human Retroviruses 11[Suppl]:S133
38. Learmont J, Tindall B, Evans L, Cunningham A, Cunningham P, Wells J, Penny R, Kaldor J, Cooper DA (1992) Long-term symptomless HIV-1-infection in recipients of blood products from a single donor. Lancet 340:863
39. Levy JA, Hoffman AD, Kramer SM, Landis JA, Shimabukuro JM, Oshiro LS (1984) Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science 225:840
40. Mackewicz CE, Ortega HW, Levy JA (1991) CD8 cell anti-HIV activity correlates with the clinical state of the infected individual. J Clin Invest 87:1462
41. + cell antiviral factor. Cell Immunol 153:329
42. + T cells suppress humin immunodeficiency virus replication by inhibiting viral transcription. Proc Natl Acad Sci USA 92:2308
43. Maddon PJ, Dalgleish AG, McDougal JS, Clapham PR, Weiss RA, Axel R (1986) The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47:333
44. Mellors JW, Kingsley LA, Rinaldo CR Jr, Todd JA, Hoo BS, Kokka RP, Gupta P (1995) Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 122:573
45. Michael NL, Vahey M, Burke DS, Redfield RR (1992) Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease. J Virol 66:310
46. Michael NL, Chang G, D'arcy LA, Ehrenberg PK, Mariani R, Busch MP, Birx DL, Schwartz DH (1995) Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus. J Virol 69:4228
47. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, Orenstein JM, Kotler DP, Fauci AS (1993) HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362:355
48. Pantaleo G, Graziosi C, and Fauci AS (1993) Mechanisms of disease, the immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 328:327
49. Pantaleo G, Menzo S, Vaccarezza M, Graziosi C, Cohen O, Demarest J, Montefiori D, Orenstein J, Fox C, Schrager L, Margolick J, Buchbinder S, Giorgi J, Fauci A (1995) Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 332:209
50. Patterson BK, Till M, Otto P, Goolsby C, Furtado MR, McBride LJ, Wolinsky SM (1993) Detection of HIV-1 DNA and messenger RNA in individual cells by PCR-driven in situ hybridization and flow cytometry. Science 260:976
51. Paxton WA, Martin SR, Tse D, O'brien TR, Skurnick J, VanDevanter NL, Padian N, Braun JF, Kotler DP, Wolinsky SM, Koup RA (1996) Relative resistance to HIV-1-infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nature Med 2:412
52. Piatak, Jr. M, Saag MS, Yang LC, Clark SJ, Kappes JC, Luk K-C, Hahn BH, Shaw GM, Lifson JD (1993) High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259:1749
53. Poli G, Fauci AS (1993) Cytokine modulation of HIV expression. Semin Immunol 5:304.1
54. + T cell derived from non-human primates. Clin Exp Immunol 91:473
55. + lymphocytes Proc Natl Acad Sci USA 91:1104
56. + T cell levels. J Acquir Immune Defic Syndr 7:1159
57. Tindall B, Cooper DA (1991) Primary HIV infection: host responses and intervention strategies. J Acquir Immune Defic Syndr 5:1
58. + lymphocytes from asymptomatic HIV-infected individuals inhibit HIV-1 replication. J Infect Dis 172: (in press)
59. Tsubota H, Lord CI, Watkins DI, Morimoto C, Letvin NL (1989) A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes. J Exp Med 169:1421
60. Walker BD, Plata F (1990) Cytotoxic T lymphocytes against HIV. J Acquir Immune Defic Syndr 4:177
61. + T lymphocytes suppresses HIV replication. Immunology 66:628
62. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234:1563
63. + cells from HIV-1-infected individuals inhibit acute infection by human and primate immunodeficiency viruses. Cell Immunol 137:420
64. + cells involves a non-cytotoxic mechanism. J Virol 65:5921